Logo-ijhpm
Original Article

1. Moving Towards Accountability for Reasonableness – A Systematic Exploration of the Features of Legitimate Healthcare Coverage Decision-Making Processes Using Rare Diseases and Regenerative Therapies as a Case Study
Monika Wagner* ORCID, Dima Samaha, Roman Casciano, Matthew Brougham, Payam Abrishami ORCID, Charles Petrie, Bernard Avouac, Lorenzo Mantovani, Antonio Sarría-Santamera ORCID, Paul Kind, Michael Schlander, Michele Tringali
Int J Health Policy Manag. 2019;8(7): 424-443. doi: i 10.15171/ijhpm.2019.24
Article
PDF
XML
Cited By:
Commentary

2. How Useful Are Early Economic Models? Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling”
James Love-Koh* ORCID
Int J Health Policy Manag. 2020;9(5): 215-217. doi: 10.15171/ijhpm.2019.119
PMCID: PMC7306112     PMID: 32563224    
Article
PDF
XML
Cited By:
Original Article

3. Priority Setting in HIV, Tuberculosis, and Malaria – New Cost-Effectiveness Results From WHO-CHOICE
Ambinintsoa H. Ralaidovy* ORCID, Jeremy Addison Lauer ORCID, Carel Pretorius, Olivier JT Briët ORCID, Edith Patouillard ORCID
Int J Health Policy Manag. 2021;10(11): 678-696. doi: 10.34172/ijhpm.2020.251
PMCID: PMC9278379     PMID: 33590743    
Article
PDF
Suppl 1
Suppl 2
XML
Cited By:
Perspective

4. Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE
Melanie Y. Bertram* ORCID, Jeremy A. Lauer ORCID, Karin Stenberg ORCID, Tessa Tan Torres Edejer ORCID
Int J Health Policy Manag. 2021;10(11): 673-677. doi: 10.34172/ijhpm.2020.244
PMCID: PMC9278384     PMID: 33619929    
Article
PDF
XML
Cited By:
Original Article

5. Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis
Melanie Y. Bertram* ORCID, Daniel Chisholm ORCID, Rory Watts ORCID, Temo Waqanivalu ORCID, Vinayak Prasad ORCID, Cherian Varghese ORCID
Int J Health Policy Manag. 2021;10(11): 724-733. doi: 10.34172/ijhpm.2021.37
PMCID: PMC9278376     PMID: 34273918    
Article
PDF
Suppl 1
Suppl 2
Suppl 3
XML
Cited By:
Editorial

6. Introduction to the Special Issue on “The World Health Organization Choosing Interventions That Are Cost-Effective (WHO-CHOICE) Update”
Melanie Y. Bertram* ORCID, Tessa Tan Torres Edejer ORCID
Int J Health Policy Manag. 2021;10(11): 670-672. doi: 10.34172/ijhpm.2021.105
PMCID: PMC9278374     PMID: 34634892    
Article
PDF
XML
Cited By:
Original Article

7. What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward
Sarin Kc ORCID, Lydia Wenxin Lin, Diana Beatriz Samson Bayani, Yaroslava Zemlyanska ORCID, Amanda Adler, Jeonghoon Ahn, Kelvin Chan, Dechen Choiphel, Anne Julienne Genuino-Marfori, Brendon Kearney, Yuehua Liu, Ryota Nakamura, Fiona Pearce, Shankar Prinja, Raoh-Fang Pwu, Arsul Akmal Shafie ORCID, Binyan Sui, Auliya Suwantika ORCID, Sean Tunis, Hui-Min Wu, John Zalcberg, Kun Zhao, Wanrudee Isaranuwatchai ORCID, Yot Teerawattananon ORCID, Hwee-Lin Wee* ORCID
Int J Health Policy Manag. 2023;12: 6858 | Published on: 2023 Mar 06. doi: 10.34172/ijhpm.2023.6858
PMCID: PMC10461954     PMID: 37579427    
Article
PDF
XML
Cited By: